Try our Advanced Search for more refined results

April 08, 2013

AstraZeneca LP v. Breath Limited

Track this case

Case Number:

13-1312

Court:

Appellate - Federal Circuit

Nature of Suit:

830 Patent Infringement (Fed. Question)

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 30, 2013

    Fed. Circ. Partially Revives AstraZeneca Asthma Drug IP Row

    The Federal Circuit on Wednesday reversed a lower court's non-infringement ruling on one patent in an intellectual property dispute over AstraZeneca PLC's Pulmicort Respules pediatric asthma medication but upheld the court's finding of obviousness on a second patent, among other issues.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!